東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Characterization of a bacterial arti...

McDowell, Erin.

FindBook

Google Book

Amazon

博客來

Characterization of a bacterial artificial chromosome (BAC)-based infectious clone of a low passage Marek's disease virus (MDV) vaccine strain, CVI988.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Characterization of a bacterial artificial chromosome (BAC)-based infectious clone of a low passage Marek's disease virus (MDV) vaccine strain, CVI988./
作者:	McDowell, Erin.
面頁冊數:	105 p.
附註:	Source: Masters Abstracts International, Volume: 48-01, page: 0317.
Contained By:	Masters Abstracts International48-01.
標題:	Biology, Molecular. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1469505
ISBN:	9781109386011

Characterization of a bacterial artificial chromosome (BAC)-based infectious clone of a low passage Marek's disease virus (MDV) vaccine strain, CVI988.
McDowell, Erin.

Characterization of a bacterial artificial chromosome (BAC)-based infectious clone of a low passage Marek's disease virus (MDV) vaccine strain, CVI988. - 105 p.

Source: Masters Abstracts International, Volume: 48-01, page: 0317.

Thesis (M.S.)--University of Delaware, 2009.

Maek's Disease (MD) is a transmissible herpesvirus infection that is characterized by paralysis, T-cell lymphoma formation and immunosuppresion in chickens. The causative agent, Marek's Disease virus (MDV), is a cell-associated alphaherpesvirus, sub-species Mardivirus. MD is controlled in commercial poultry production through vaccination, but field strains of MDV continue to evolve in virulence. The most efficacious vaccine commercially available is CVI988 (Rispens) that was developed as a vaccine after attenuation in cell culture at passage 33 (p33). As CVI988 vaccines from different suppliers vary in efficacy, we sought to construct a bacterial artificial chromosome (BAC)-bases infectious clone of low passage (<p25). DNA from p19 CVI988 was obtained from the Central Veterinary Institute, Lelystad via a collaborator in France. This DNA was co-transfected into CEF along with BAC transfer vector (pDS-HA-1), passaged in selection, and subsequent BAC-containing viruses were electroporated into E.coli to give rise to CVI988-BAC clones. One particular clone, CVI988-BAC, 699-2 (isolated from chicken #699) had the BAC sequences subsequently deleted through Cre-mediated recombination to yield CVI988, 699-2Delta. This BAC-deleted virus was subsequently tested in three large-scale efficacy trials and was found to provide protection against a vv+MDV challenge with efficacy superior to the commercial CVI988 vaccines tested. Upon serial back-passage in specific pathogen free (SPF) leghorn chickens however, CVI988, 699-2Delta induced microscopic tumors at back passages 3 and 5, and when administered at a 10X dose indicating a reversion to virulence. Our data demonstrate that very minute differences exist between a highly-efficacious vaccine and one that has pathogenic potential.

ISBN: 9781109386011Subjects--Topical Terms:

1017719
Biology, Molecular.

Characterization of a bacterial artificial chromosome (BAC)-based infectious clone of a low passage Marek's disease virus (MDV) vaccine strain, CVI988.
LDR:02944nam 2200337 4500 001 1390776
005 20101022135933.5
008 130515s2009 ||||||||||||||||| ||eng d
020 $a 9781109386011
035 $a (UMI)AAI1469505
035 $a AAI1469505
040 $a UMI $c UMI
100 1 $a McDowell, Erin. $3 1669097
245 1 0 $a Characterization of a bacterial artificial chromosome (BAC)-based infectious clone of a low passage Marek's disease virus (MDV) vaccine strain, CVI988.
300 $a 105 p.
500 $a Source: Masters Abstracts International, Volume: 48-01, page: 0317.
500 $a Adviser: Mark Parcells.
502 $a Thesis (M.S.)--University of Delaware, 2009.
520 $a Maek's Disease (MD) is a transmissible herpesvirus infection that is characterized by paralysis, T-cell lymphoma formation and immunosuppresion in chickens. The causative agent, Marek's Disease virus (MDV), is a cell-associated alphaherpesvirus, sub-species Mardivirus. MD is controlled in commercial poultry production through vaccination, but field strains of MDV continue to evolve in virulence. The most efficacious vaccine commercially available is CVI988 (Rispens) that was developed as a vaccine after attenuation in cell culture at passage 33 (p33). As CVI988 vaccines from different suppliers vary in efficacy, we sought to construct a bacterial artificial chromosome (BAC)-bases infectious clone of low passage (<p25). DNA from p19 CVI988 was obtained from the Central Veterinary Institute, Lelystad via a collaborator in France. This DNA was co-transfected into CEF along with BAC transfer vector (pDS-HA-1), passaged in selection, and subsequent BAC-containing viruses were electroporated into E.coli to give rise to CVI988-BAC clones. One particular clone, CVI988-BAC, 699-2 (isolated from chicken #699) had the BAC sequences subsequently deleted through Cre-mediated recombination to yield CVI988, 699-2Delta. This BAC-deleted virus was subsequently tested in three large-scale efficacy trials and was found to provide protection against a vv+MDV challenge with efficacy superior to the commercial CVI988 vaccines tested. Upon serial back-passage in specific pathogen free (SPF) leghorn chickens however, CVI988, 699-2Delta induced microscopic tumors at back passages 3 and 5, and when administered at a 10X dose indicating a reversion to virulence. Our data demonstrate that very minute differences exist between a highly-efficacious vaccine and one that has pathogenic potential.
590 $a School code: 0060.
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Agriculture, Animal Culture and Nutrition. $3 1017857
650 4 $a Biology, Virology. $3 1019068
690 $a 0307
690 $a 0475
690 $a 0720
710 2 $a University of Delaware. $b Department of Animal and Food Sciences. $3 1029904
773 0 $t Masters Abstracts International $g 48-01.
790 1 0 $a Parcells, Mark, $e advisor
790 1 0 $a Parcells, Mark $e committee member
790 1 0 $a Gelb, Jack $e committee member
790 1 0 $a Schmidt, Carl $e committee member
790 1 0 $a Bublot, Michel $e committee member
790 $a 0060
791 $a M.S.
792 $a 2009
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1469505